Zobrazeno 1 - 4
of 4
pro vyhledávání: '"O. M. Lazutina"'
Autor:
O. M. Lazutina, T. V. Smorkalova, I. S. Mikhailova, K. Yu. Bondar, O. L. Belaya, Z. V. Kuropteva, L. M. Baider
Publikováno v:
Clinical Medicine (Russian Journal). 95:398-403
The gender-specific features of cardiovascular diseases (CVD) are actively being discussed which puts on the agenda the development of a differentiated approach to the treatment of cardiac diseases in men and women. Аim. To assess the gender-specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87d3d51f6d0b289199134737c1485472
https://doi.org/10.18821/0023-2149-2017-95-5-398-403
https://doi.org/10.18821/0023-2149-2017-95-5-398-403
Publikováno v:
Klinicheskaia meditsina. 91(4)
Paraneoplastic syndromes have a variety of clinical manifestations most frequently resembling systemic diseases and phlebothrombosis. Also, hypercoagulative paraneoplasic syndrome may have some clinical features of myocardial infarction which makes d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf42f5c119503eb3392739dfabe37ca7
https://pubmed.ncbi.nlm.nih.gov/23879060
https://pubmed.ncbi.nlm.nih.gov/23879060
Autor:
K Yu, Bondar, O L, Belaya, O M, Lazutina, Z V, Kuropteva, L M, Raider, N E, Artamoshina, T V, Yakovleva
Publikováno v:
Klinicheskaia meditsina. 90(10)
The aim of the work was to study the role of atorvastatin in the correction of oxidative stress manifestations in patients with coronary heart disease and dyslipidemnia (DLP). It included 122 patients with stable forms of CHD and 20 practically healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6adbc4992b67d1790eb5288c2468ee6e
https://pubmed.ncbi.nlm.nih.gov/23285760
https://pubmed.ncbi.nlm.nih.gov/23285760
Autor:
E Iu, Dorofeeva, V A, Gorshkov, V V, Chestukhin, V V, Lyskovtsev, A B, Bezprozvannyĭ, E D, Avdeĭchuk, G V, Kesarev, O M, Lazutina, V N, Nesvetov, A E, Radzevich
Publikováno v:
Terapevticheskii arkhiv. 69(8)
Therapeutic and prophylactic antiarrhythmic efficacy of sotalol hydrochloride (Sotahexal, "Hexal", Germany) and its effects in intracardiac hemodynamics and ECG parameters were evaluated in 95 patients with ischemic heart disease (IHD). The highest r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5348db8c8d14f8240de9b0f1d9e0d2d5
https://pubmed.ncbi.nlm.nih.gov/9381384
https://pubmed.ncbi.nlm.nih.gov/9381384